Helicobacter pylori infection and insulin resistance

Helicobacter

Volumn 18, Issue 2, 2013, Pages 165-166

  Polyzos, Stergios A ^a   Kountouras, Jannis ^a   Zavos, Christos ^a   Deretzi, Georgia ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; INSULIN; PROTON PUMP INHIBITOR;

BODY MASS; DIABETES MELLITUS; DISEASE ASSOCIATION; ERADICATION THERAPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; INSULIN RESISTANCE; LEBANON; LETTER; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER DISEASE ACTIVITY SCORE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SEROLOGY; WAIST CIRCUMFERENCE;

EID: 84875018221     PISSN: 10834389     EISSN: 15235378     Source Type: Journal    
DOI: 10.1111/hel.12019     Document Type: Letter

References (6)

1. Naja F, Nasreddine L, Hwalla N, Moghames P, Shoaib H, Fatfat M, Sibai A, Gali-Muhtasib H. Association of H. pylori infection with insulin resistance and metabolic syndrome among Lebanese adults. Helicobacter 2012. doi: 10.1111/j.1523-5378.2012.00970.x. (epub ahead of print)
2. Polyzos SA, Kountouras J, Zavos C, Deretzi G. The association between Helicobacter pylori infection and insulin resistance: a systematic review. Helicobacter 2011;16:79-88.
3. Sharara AI, bdul-Baki H, ElHajj I, Kreidieh N, Kfoury Baz EM. Association of gastroduodenal disease phenotype with ABO blood group and Helicobacter pylori virulence-specific serotypes. Dig Liver Dis 2006;38:829-33.
4. Jeon CY, Haan MN, Cheng C, Clayton ER, Mayeda ER, Miller JW, Aiello AE. Helicobacter pylori infection is associated with an increased rate of diabetes. Diabetes Care 2012;35:520-5.
5. Polyzos SA, Kountouras J, Zavos C, Deretzi G. Comment on: Jeon et al. Helicobacter pylori infection is associated with an increased rate of diabetes. Diabetes Care 2012;35:520-5. Diabetes Care 2012;35:e53.
6. Polyzos SA, Kountouras J, Papatheodorou A, Patsiaoura K, Katsiki E, Zafeiriadou E, Zavos C, Anastasiadou K, Terpos E. Helicobacter pylori infection in patients with nonalcoholic fatty liver disease. Metabolism 2012. doi: 10.1016/j.metabol.2012.06.007 (epub ahead of print).